Rongyang Dai

577 citations
21 papers · 444 indexed · h-index 11
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers)Ubiquitin and proteasome pathways (4 papers)Cancer Mechanisms and Therapy (3 papers)
Partner nations
ChinaFinlandMacao

In The Last Decade

Rongyang Dai

19 papers receiving 441 citations

Peers

Rongyang Dai
Comparison fields: 5 of 71
  • Molecular Biology 266
  • Epidemiology 124
  • Cancer Research 121
  • Pulmonary and Respiratory Medicine 88
  • Cell Biology 88
Replace Stacey L. Lehman with:
Stacey L. Lehman United States
Benxin Hou China
Aristeidis E. Boukouris Canada
Avi Kumar United States
Jun Ouyang China
Yuening Sun China
Boyun Shi China
Beatrice Conti Italy
Derek A. Franklin United States
Rongyang Dai relative to Stacey L. Lehman United States Stacey L. Lehman's profile →
Citations per field
00.5×2.8×
Stacey L. Lehman · 1×
Citations per year

Countries citing papers authored by Rongyang Dai

Since Specialization
Citations

This map shows the geographic impact of Rongyang Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongyang Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongyang Dai more than expected).

Fields of papers citing papers by Rongyang Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongyang Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongyang Dai. The network helps show where Rongyang Dai may publish in the future.

Co-authorship network of co-authors of Rongyang Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Rongyang Dai. A scholar is included among the top collaborators of Rongyang Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongyang Dai. Rongyang Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 1
5 4
6 10
7 48
8 4
9 14
10 13
11 37
12 3
13 22
14 5
15 13
16 20
17 116
18 7
19 25
20 91

About Rongyang Dai

Rongyang Dai is a scholar working on Geriatrics and Gerontology, Cell Biology and Pathology and Forensic Medicine, having authored 21 papers that have together received 444 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Ubiquitin and proteasome pathways (4 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Cancer Research (121 citations), Cell Biology (88 citations) and Molecular Biology (266 citations). Rongyang Dai has collaborated with scholars based in China, Finland and Macao. Frequent co-authors include Chunyan Duan, Xiaofang Zhao, Yi Zeng, Yini Liu, Bo Cheng, Chunhong Feng, Bin Xiao, Tao Luo, Juan Li and Ning Li. Their work appears in journals such as International Journal of Molecular Sciences, Annals of the Rheumatic Diseases and International Journal of Biological Macromolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026